About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 729819, 7 pages
http://dx.doi.org/10.1155/2013/729819
Clinical Study

Better Survival with Three-Dimensional Conformal Radiotherapy Than with Conventional Radiotherapy for Cervical Cancer: A Population-Based Study

1Department of Radiation Oncology, Far Eastern Memorial Hospital, Taipei 220, Taiwan
2Department of Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan
3Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan
4Department of Radiation Oncology, Buddhist Dalin Tzu Chi General Hospital, Chiayi 622, Taiwan
5School of Medicine, Tzu Chi University, Hualien 970, Taiwan

Received 4 July 2013; Accepted 27 August 2013

Academic Editors: C. Damodaran and H. M. Warenius

Copyright © 2013 Chen-Hsi Hsieh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Pisani, D. M. Parkin, F. Bray, and J. Ferlay, “Estimates of the worldwide mortality from 25 cancers in 1990,” International Journal of Cancer Journal International Du Cancer, vol. 83, no. 1, pp. 18–29, 1999.
  2. P. G. Rose, B. N. Bundy, E. B. Watkins et al., “Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer,” New England Journal of Medicine, vol. 340, no. 15, pp. 1144–1153, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. W. A. Peters III, P. Y. Liu, R. J. Barrett II et al., “Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix,” Journal of Clinical Oncology, vol. 18, no. 8, pp. 1606–1613, 2000. View at Scopus
  4. J. L. Forrest, I. Ackerman, L. Barbera et al., “Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix,” International Journal of Gynecological Cancer, vol. 20, no. 6, pp. 1074–1078, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Huguet, O.-M. Cojocariu, P. Levy et al., “Preoperative concurrent radiation therapy and chemotherapy for bulky stageIB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 5, pp. 1508–1515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Snijders-Keilholz, M. Von Acht, H. De Vroome, J. Hermans, J. B. Trimbos, and J. W. H. Leer, “Pelvic failure rate and radiation toxicity in relation to total dose of radiation alone for the treatment of cancer of the uterine cervix,” Clinical Oncology, vol. 5, no. 1, pp. 6–10, 1993. View at Scopus
  7. M. T. M. Davidson, J. Yuen, D. P. D'Souza, and D. L. Batchelar, “Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?” Brachytherapy, vol. 7, no. 1, pp. 37–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Ferrigno, P. E. R. dos Santos Novaes, A. C. A. Pellizzon et al., “High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications,” International Journal of Radiation Oncology Biology Physics, vol. 50, no. 5, pp. 1123–1135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Roeske, A. J. Mundt, H. Halpern et al., “Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis,” International Journal of Radiation Oncology Biology Physics, vol. 37, no. 2, pp. 351–358, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Dale, T. P. Hellebust, A. Skjønsberg, T. Høgberg, and D. R. Olsen, “Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 4, pp. 963–971, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Gallagher, H. D. Brereton, R. A. Rostock, et al., “A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 12, no. 9, pp. 1565–1573, 1986. View at Scopus
  12. C. A. Perez, P. W. Grigsby, K. S. C. Chao, D. G. Mutch, and M. A. Lockett, “Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix,” International Journal of Radiation Oncology Biology Physics, vol. 41, no. 2, pp. 307–317, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Bonin, R. M. Lanciano, B. W. Corn, W. M. Hogan, W. H. Hartz, and G. E. Hanks, “Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 34, no. 1, pp. 167–172, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Zunino, O. Rosato, S. Lucino, E. Jauregui, L. Rossi, and D. Venencia, “Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique,” International Journal of Radiation Oncology Biology Physics, vol. 44, no. 1, pp. 53–59, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. J. McAlpine, J. B. Schlaerth, P. Lim, D. Chen, S. M. Eisenkop, and N. M. Spirtos, “Radiation fields in gynecologic oncology: correlation of soft tissue (surgical) to radiologic landmarks,” Gynecologic Oncology, vol. 92, no. 1, pp. 25–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Gerstner, S. Wachter, T. H. Knocke, C. Fellner, A. Wambersie, and R. Pötter, “The benefit of Beam's eye view based 3D treatment planning for cervical cancer,” Radiotherapy and Oncology, vol. 51, no. 1, pp. 71–78, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. J. Olofsen-van Acht, S. Quint, M. Seven et al., “Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer. Comparison between a conventional and a conformal technique,” Strahlentherapie und Onkologie, vol. 175, no. 9, pp. 462–469, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. P. C. M. Koper, J. C. Stroom, W. L. J. van Putten et al., “Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study,” International Journal of Radiation Oncology Biology Physics, vol. 43, no. 4, pp. 727–734, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. R. G. Stock, “Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 1, pp. 31–36, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Suprasert, K. Charoenkwan, and S. Khunamornpong, “Pelvic node removal and disease-free survival in cervical cancer patients treated with radical hysterectomy and pelvic lymphadenectomy,” International Journal of Gynecology and Obstetrics, vol. 116, no. 1, pp. 43–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Y. Kim, “Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss,” Radiotherapy and Oncology, vol. 30, no. 2, pp. 140–145, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. A. H. Russell, J. P. Walter, M. W. Anderson, and C. L. Zukowski, “Sagittal magnetic resonance imaging in the design of lateral radiation treatment portals for patients with locally advanced squamous cancer of the cervix,” International Journal of Radiation Oncology Biology Physics, vol. 23, no. 2, pp. 449–455, 1992. View at Scopus
  23. S. C. Pendlebury, S. Cahill, A. J. Crandon, and C. A. Bull, “Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer,” International Journal of Radiation Oncology Biology Physics, vol. 27, no. 4, pp. 959–962, 1993. View at Scopus
  24. L. Souhami, R. Seymour, T. N. Roman et al., “Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix,” International Journal of Radiation Oncology Biology Physics, vol. 27, no. 4, pp. 871–878, 1993. View at Scopus
  25. H. M. Keys, B. N. Bundy, F. B. Stehman et al., “Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma,” New England Journal of Medicine, vol. 340, no. 15, pp. 1154–1161, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Eifel, K. Winter, M. Morris et al., “Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 872–880, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Rotman, T. F. Pajak, K. Choi et al., “Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20,” The Journal of the American Medical Association, vol. 274, no. 5, pp. 387–393, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. P. W. Grigsby, K. Heydon, D. G. Mutch, R. Y. Kim, and P. Eifel, “Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 4, pp. 982–987, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. E. Ellis, “The distribution of active bone marrow in the adult,” Physics in Medicine and Biology, vol. 5, no. 3, article 302, pp. 255–258, 1961. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Sood, G. R. Gorla, M. Garg et al., “Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy,” Cancer, vol. 97, no. 7, pp. 1781–1788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. G. E. Hanks, W. R. Lee, A. L. Hanlon et al., “Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≤10 ng/ml,” International Journal of Radiation Oncology Biology Physics, vol. 35, no. 5, pp. 861–868, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. G. E. Hanks, T. E. Schultheiss, M. A. Hunt, and B. Epstein, “Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 1, pp. 25–29, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Michalski, K. Winter, J. A. Purdy et al., “Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV,” International Journal of Radiation Oncology Biology Physics, vol. 58, no. 3, pp. 735–742, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Michalski, K. Winter, J. A. Purdy et al., “Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 1, pp. 192–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-H. Tseng, “Mortality and causes of death in a national sample of diabetic patients in Taiwan,” Diabetes Care, vol. 27, no. 7, pp. 1605–1609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. P. Hopkins and G. W. Morley, “Stage 1B squamous cell cancer of the cervix: clinicopathologic features related to survival,” American Journal of Obstetrics and Gynecology, vol. 164, no. 6, part 1, pp. 1520–1529, 1991. View at Scopus
  37. D. S. Kapp, D. Fischer, and E. Gutierrez, “Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival,” International Journal of Radiation Oncology Biology Physics, vol. 9, no. 4, pp. 445–455, 1983. View at Scopus